Paper33112397
Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
Schmid S and 35 others. JAMA Netw Open, 2020. Cited by 99 papers, by iCite.
Cite this record
ConductScience Library. Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations. Papers, record 33112397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33112397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Repair-Deficiency Disorders | Major topic |
| Drug Therapy | Major topic |
| Platinum Compounds | Major topic |
| Prostatic Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Antineoplastic Agents | |
| Docetaxel | |
| Humans | |
| Male | |
| Middle Aged | |
| Paclitaxel | |
| Retrospective Studies |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed |
Source NIH RePORTER
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 33206186 | Errors in Byline, Affiliations, and Conflict of Interest Disclosures. | https://conductscience.org/library/papers/33206186 | PubMed |
| Comment in | 33112396 | Homologous Recombination DNA Repair Gene Aberrations-Are We More Alike Than Different? | https://conductscience.org/library/papers/33112396 | PubMed |
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19805692 | Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19805692 | PubMed |
| 2 | 26903579 | Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/26903579 | PubMed |
| 3 | 31515154 | Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial. | Lancet Oncol | 2019 | https://conductscience.org/library/papers/31515154 | PubMed |
| 4 | 19179557 | Combining carboplatin and etoposide in docetaxel-pretreated patients with castration-resistant prostate cancer: a prospective study evaluating also neuroendocrine features. | Ann Oncol | 2009 | https://conductscience.org/library/papers/19179557 | PubMed |
| 5 | 19553641 | Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19553641 | PubMed |
| 6 | 29713086 | Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. | Nat Med | 2018 | https://conductscience.org/library/papers/29713086 | PubMed |
| 7 | 28655541 | Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. | Eur Urol | 2018 | https://conductscience.org/library/papers/28655541 | PubMed |
| 8 | 15829966 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. | Nature | 2005 | https://conductscience.org/library/papers/15829966 | PubMed |
| 9 | 31958182 | Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer. | Cancer Sci | 2020 | https://conductscience.org/library/papers/31958182 | PubMed |
| 10 | 22722839 | The mutational landscape of lethal castration-resistant prostate cancer. | Nature | 2012 | https://conductscience.org/library/papers/22722839 | PubMed |
| 11 | 32086346 | Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study. | Clin Cancer Res | 2020 | https://conductscience.org/library/papers/32086346 | PubMed |
| 12 | 31806540 | Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. | Lancet Oncol | 2020 | https://conductscience.org/library/papers/31806540 | PubMed |
| 13 | 22981675 | Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity. | Eur Urol | 2013 | https://conductscience.org/library/papers/22981675 | PubMed |
| 14 | 32343890 | Olaparib for Metastatic Castration-Resistant Prostate Cancer. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32343890 | PubMed |
| 15 | 26510020 | DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26510020 | PubMed |
| 16 | 25058905 | Cisplatin in cancer therapy: molecular mechanisms of action. | Eur J Pharmacol | 2014 | https://conductscience.org/library/papers/25058905 | PubMed |
| 17 | 28723506 | Biomarkers for Metastatic Castration-resistant Prostate Cancer (mCRPC): Yes or No? Predictive and Response Biomarkers Towards Precision Medicine in mCRPC. | Eur Urol Focus | 2016 | https://conductscience.org/library/papers/28723506 | PubMed |
| 18 | 23118055 | Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Cancer Res | 2012 | https://conductscience.org/library/papers/23118055 | PubMed |
| 19 | 15829967 | Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. | Nature | 2005 | https://conductscience.org/library/papers/15829967 | PubMed |
| 20 | 30625039 | PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer. | J Clin Oncol | 2019 | https://conductscience.org/library/papers/30625039 | PubMed |
Cited by61
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42423955 | Platinum-based chemotherapy in metastatic castration-resistant prostate cancer: a narrative review and dual stratification framework based on HRR genotype and aggressive-variant/neuroendocrine phenotype. | Int Urol Nephrol | 2026 | https://conductscience.org/library/papers/42423955 | PubMed |
| 42418738 | Shallow Whole-Genome Sequencing to Assess Genomic Instability and Predict Treatment Response in Metastatic Castration-Resistant Prostate Cancer. | JCO Precis Oncol | 2026 | https://conductscience.org/library/papers/42418738 | PubMed |
| 41789650 | Targeting poly(ADP-ribose) polymerase in metastatic prostate cancer: current landscape and future directions. | Curr Opin Oncol | 2026 | https://conductscience.org/library/papers/41789650 | PubMed |
| 41709957 | Studies on the functionality of the TC-NER ERCC6-M1097V protein variant frequently found in Louisiana patients with PCa upon UV damage. | Front Oncol | 2025 | https://conductscience.org/library/papers/41709957 | PubMed |
| 41373813 | Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging Treatment. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373813 | PubMed |
| 41304997 | YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304997 | PubMed |
| 40596117 | Mutational and low-coverage whole genome sequencing identifies actionable DNA repair alterations in prostate cancer plasma DNA. | Sci Rep | 2025 | https://conductscience.org/library/papers/40596117 | PubMed |
| 40558268 | Incidence and Risk Factors of Platinum-Based Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. | Curr Oncol | 2025 | https://conductscience.org/library/papers/40558268 | PubMed |
| 40542015 | Impact of adding carboplatin to docetaxel chemotherapy on testosterone levels and treatment outcomes in metastatic docetaxel-resistant prostate cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40542015 | PubMed |
| 40293712 | Combining Spatial Transcriptomics, Pseudotime, and Machine Learning Enables Discovery of Biomarkers for Prostate Cancer. | Cancer Res | 2025 | https://conductscience.org/library/papers/40293712 | PubMed |
| 39793235 | Activity of Platinum Chemotherapy in Men With Prostate Cancer With and Without DNA Damage Repair Mutations. | Clin Genitourin Cancer | 2025 | https://conductscience.org/library/papers/39793235 | PubMed |
| 39616467 | Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024. | Cancer | 2025 | https://conductscience.org/library/papers/39616467 | PubMed |
| 39611376 | Prostate cancer and genetic contributions. | Andrology | 2025 | https://conductscience.org/library/papers/39611376 | PubMed |
| 39438537 | Synergistic effects of bloom helicase (BLM) inhibitor AO/854 with cisplatin in prostate cancer. | Sci Rep | 2024 | https://conductscience.org/library/papers/39438537 | PubMed |
| 39183332 | Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39183332 | PubMed |
| 38730575 | Amino Terminal Acetylation of HOXB13 Regulates the DNA Damage Response in Prostate Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38730575 | PubMed |
| 38453159 | Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer Harboring Somatic or Germline Homologous Recombination Repair Gene Mutations: Phase II Single-Arm Trial. | JMIR Res Protoc | 2024 | https://conductscience.org/library/papers/38453159 | PubMed |
| 38425504 | Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial. | Ther Adv Urol | 2024 | https://conductscience.org/library/papers/38425504 | PubMed |
| 38416404 | Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types. | Clin Cancer Res | 2024 | https://conductscience.org/library/papers/38416404 | PubMed |
| 38396858 | Precision Medicine in Castration-Resistant Prostate Cancer: Advances, Challenges, and the Landscape of PARPi Therapy-A Narrative Review. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396858 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| PTEN | 5728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
| RB1 | 5925 | PubTator's text mining | https://conductscience.org/library/genes/5925 | NCBI Gene |
| SPARC | 6678 | PubTator's text mining | https://conductscience.org/library/genes/6678 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33112397
GET https://conductscience.org/api/papers/v1/33112397/authors?page=2